Cleared Traditional

K212161 - Radical-7 Pulse CO-Oximeter and Accesso...

K212161 is the FDA 510(k) clearance for Radical-7 Pulse CO-Oximeter and Accesso... by Masimo Corporation. It is a Class 2 Anesthesiology device (product code MWI) cleared through the Traditional 510(k) pathway after a 602-day FDA review.

K212161 · Masimo Corporation · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2023
Decision
602d
Days
Class 2
Risk

K212161 is an FDA 510(k) clearance for the Radical-7 Pulse CO-Oximeter and Accessories, Rad-97 and Accessories. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Masimo Corporation (Irvine, US). The FDA issued a Cleared decision on March 6, 2023 after a review of 602 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 870.2300 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Anesthesiology submissions.

View all Masimo Corporation devices

Submission Details

510(k) Number K212161 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 12, 2021
Decision Date March 06, 2023
Days to Decision 602 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
462d slower than avg
Panel avg: 140d · This submission: 602d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 123
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K212161.
ARC Intensive Care Information System (ARC System)
K220117 · Ordinatrum Solutions · Jun 2023
Huma RPM (RPM)
K230214 · Medopad, Inc. · Jun 2023
The Heart Seat
K222330 · Casana Care, Inc. · Apr 2023
VS 8 Vital Signs Monitor, VS 8A Vital Signs Monitor, VS 9 Vital Signs Monitor
K221267 · Shenzhen Mindray Bio-Meidcal Electronics Co., Ltd. · Dec 2022
Accutorr 3 Vital Signs Monitor, Rosebud Vital Signs Monitor
K221113 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Dec 2022
Welch Allyn Connex Central Station
K212473 · Welch Allyn, Inc. · Oct 2022